CGTX
Price
$1.75
Change
-$0.05 (-2.78%)
Updated
Dec 4, 04:59 PM (EDT)
Capitalization
158.89M
118 days until earnings call
Intraday BUY SELL Signals
TCRX
Price
$1.10
Change
+$0.08 (+7.84%)
Updated
Dec 4, 04:59 PM (EDT)
Capitalization
57.88M
97 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CGTX vs TCRX

Header iconCGTX vs TCRX Comparison
Open Charts CGTX vs TCRXBanner chart's image
Cognition Therapeutics
Price$1.75
Change-$0.05 (-2.78%)
Volume$7.48K
Capitalization158.89M
TScan Therapeutics
Price$1.10
Change+$0.08 (+7.84%)
Volume$12.56K
Capitalization57.88M
CGTX vs TCRX Comparison Chart in %
CGTX
Daily Signal:
Gain/Loss:
TCRX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CGTX vs. TCRX commentary
Dec 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGTX is a StrongBuy and TCRX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 05, 2025
Stock price -- (CGTX: $1.80 vs. TCRX: $1.02)
Brand notoriety: CGTX and TCRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CGTX: 146% vs. TCRX: 86%
Market capitalization -- CGTX: $158.89M vs. TCRX: $57.88M
CGTX [@Biotechnology] is valued at $158.89M. TCRX’s [@Biotechnology] market capitalization is $57.88M. The market cap for tickers in the [@Biotechnology] industry ranges from $117.5B to $0. The average market capitalization across the [@Biotechnology] industry is $2.2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGTX’s FA Score shows that 1 FA rating(s) are green whileTCRX’s FA Score has 1 green FA rating(s).

  • CGTX’s FA Score: 1 green, 4 red.
  • TCRX’s FA Score: 1 green, 4 red.
According to our system of comparison, CGTX is a better buy in the long-term than TCRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGTX’s TA Score shows that 5 TA indicator(s) are bullish while TCRX’s TA Score has 6 bullish TA indicator(s).

  • CGTX’s TA Score: 5 bullish, 4 bearish.
  • TCRX’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, TCRX is a better buy in the short-term than CGTX.

Price Growth

CGTX (@Biotechnology) experienced а +9.09% price change this week, while TCRX (@Biotechnology) price change was -8.11% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.21%. For the same industry, the average monthly price growth was +5.86%, and the average quarterly price growth was +56.03%.

Reported Earning Dates

CGTX is expected to report earnings on Apr 01, 2026.

TCRX is expected to report earnings on Mar 11, 2026.

Industries' Descriptions

@Biotechnology (+1.21% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CGTX($159M) has a higher market cap than TCRX($57.9M). CGTX YTD gains are higher at: 156.666 vs. TCRX (-66.447). CGTX has higher annual earnings (EBITDA): -32.73M vs. TCRX (-130.55M). TCRX has more cash in the bank: 218M vs. CGTX (10.7M). CGTX has less debt than TCRX: CGTX (468K) vs TCRX (96.7M). TCRX has higher revenues than CGTX: TCRX (6.96M) vs CGTX (0).
CGTXTCRXCGTX / TCRX
Capitalization159M57.9M275%
EBITDA-32.73M-130.55M25%
Gain YTD156.666-66.447-236%
P/E RatioN/AN/A-
Revenue06.96M-
Total Cash10.7M218M5%
Total Debt468K96.7M0%
TECHNICAL ANALYSIS
Technical Analysis
CGTXTCRX
RSI
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
80%
MACD
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 7 days ago
82%
Bullish Trend 16 days ago
81%
Declines
ODDS (%)
Bearish Trend 15 days ago
90%
Bearish Trend 14 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
85%
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
CGTX
Daily Signal:
Gain/Loss:
TCRX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
XBOTF0.310.01
+2.37%
REALBOTIX CORP
RIOFF1.780.02
+1.14%
RIO2 Limited
VWSYF24.740.01
+0.02%
Vestas Wind Systems A/S
MAPIF1.44N/A
N/A
Mapletree Industrial Trust
IGLDF1.97N/A
N/A
Internet Gold-Golden Lines Ltd.

CGTX and

Correlation & Price change

A.I.dvisor tells us that CGTX and LGVN have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CGTX and LGVN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGTX
1D Price
Change %
CGTX100%
+11.80%
LGVN - CGTX
31%
Poorly correlated
-1.16%
KALV - CGTX
30%
Poorly correlated
+8.43%
HYFT - CGTX
29%
Poorly correlated
+6.86%
RGNX - CGTX
29%
Poorly correlated
+5.49%
TCRX - CGTX
29%
Poorly correlated
+7.12%
More

TCRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TCRX has been loosely correlated with FATE. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if TCRX jumps, then FATE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TCRX
1D Price
Change %
TCRX100%
+7.12%
FATE - TCRX
41%
Loosely correlated
+7.46%
MGNX - TCRX
39%
Loosely correlated
-1.41%
KURA - TCRX
38%
Loosely correlated
+7.55%
ELVN - TCRX
37%
Loosely correlated
+2.14%
ZNTL - TCRX
36%
Loosely correlated
+2.99%
More